Fierce Virtual Series: JPM Week 2021 has ended

Create Your Own Event

Fierce Virtual Series: JPM Week 2021

GN

George Naumov

RS Oncology
COO & Head of Business Development
Cambridge, MA

RS Oncology has identified a new metabolic target in the mitochondria of cells. We are currently entering Phase 1/2 clinical development in cancer with focus on Mesothelioma and Ovarian cancer. I am open to discuss possible partnerships.

9:30am EST

Open for Networking

10:00am EST

"Second-Wave" COVID-19 Vaccines

10:50am EST

Innovating in a Crisis

11:15am EST

Executive Interview: Ruud Dobber, Executive Vice President and President, BioPharmaceuticals Business Unit, AstraZeneca

11:30am EST

Optimizing Successful Commercialization with Advanced Analytics

12:00pm EST

Networking Break

1:00pm EST

Manufacturing innovation across new modalities

1:35pm EST

Executive Interview: Stéphane Bancel, Chief Executive Officer, Moderna

2:00pm EST

Biopharma production agility through orchestration

2:30pm EST

Networking Break

3:00pm EST

Executive Interview: Guido Seidel, Ph.D., Vice President Biopharma, WACKER Chemie

3:10pm EST

Executive Interview: Joe Jimenez, Co-Founder and Managing Director, Aditum Bio

3:30pm EST

Executive Interview: Martin Meeson, CEO Fujifilm Diosynth Biotechnologies

3:45pm EST

Rerouting: How real-time patient data will drive the future of healthcare

4:15pm EST

Executive Interview: George Scangos, CEO, Vir